Abstract
Single-dose administration of 5-hydroxytryptophan (5-HTP) is regularly used as a challenge test of the serotonergic system. The use of 5-HTP has been limited by an apparent small window between the occurrence of neuroendocrine endpoints and the occurrence of side effects. Therefore, many dosing strategies have been tried with and without concurrent administration of carbidopa, a peripheral inhibitor of the decarboxylation from 5-HTP to serotonin. The aim of the current study was to assess the relation between pharmacokinetics and pharmacodynamics of 5-HTP. Twelve healthy male volunteers were included in a placebo-controlled, randomized, four-way crossover, double-blind, single-dose investigation of oral 5-HTP with or without coadministration of carbidopa. The four dose regimens were placebo, 5-HTP 100 mg, 5-HTP 200 mg, and 5-HTP 100 mg with coadministration of carbidopa 100 mg and 50 mg at 3 hours before and 3 hours after the administration of 5-HTP, respectively. The last regimen resulted in a doubling of the elimination half-life, an apparent clearance at least 14 times smaller, and a 15.4 times greater area under the curve compared with 5-HTP 100 mg without carbidopa. Furthermore, it was the only regimen to induce a signific...Continue Reading
References
Jul 1, 1978·Acta Pharmacologica Et Toxicologica·I Magnussen, F Engbaek
Apr 1, 1979·Acta Pharmacologica Et Toxicologica·I Magnussen, F Nielsen-Kudsk
Jan 1, 1979·Psychoneuroendocrinology·P E GarfinkelH C Stancer
Jan 1, 1976·Drugs·M T Roberts
Jan 1, 1976·Drugs·R M PinderG S Avery
Feb 1, 1975·Journal of Medicinal Chemistry·S VickersH B Hucker
Jul 1, 1976·The Journal of Clinical Endocrinology and Metabolism·G M BrownH C Stancer
Jan 1, 1992·Neuropharmacology·S E GartsideT Sharp
Nov 15, 1991·Biological Psychiatry·M A Lee, H Y Meltzer
Jan 1, 1991·Psychopharmacology·M A LeeH Y Meltzer
Aug 1, 1991·Clinical Pharmacology and Therapeutics·A L van SteveninckA F Cohen
Mar 1, 1990·Psychiatry Research·J A den Boer, H G Westenberg
Apr 10, 1990·European Journal of Pharmacology·S E Gartside, P J Cowen
Jan 1, 1990·Annals of the New York Academy of Sciences·P J CowenS E Gartside
Aug 1, 1989·Experimental Neurology·J E AhlskogS W Carmichael
Sep 1, 1981·Acta Pharmacologica Et Toxicologica·I MagnussenM H Van Woert
Dec 1, 1982·Psychiatry Research·H G WestenbergH M van Praag
Apr 1, 1984·Archives of General Psychiatry·H Y MeltzerR Perline
Dec 1, 1982·Psychiatry Research·H G WestenbergJ H Thijssen
May 1, 1994·Psychopharmacology·H Y Meltzer, M Maes
May 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·I M van VlietJ A Den Boer
Sep 1, 1996·British Journal of Clinical Pharmacology·R C Schoemaker, A F Cohen
Mar 1, 1997·Chest·D W Hudgel, E A Gordon
Jul 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·H MeltzerM Maes
Apr 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·P A SargentP J Cowen
Aug 5, 1998·Journal of Clinical Psychopharmacology·H J GijsmanG M Van Kempen
Citations
May 17, 2005·Medical Hypotheses·Erick H Turner, Aaron D Blackwell
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·David J BrunswickJay D Amsterdam
Apr 9, 2009·American Journal of Therapeutics·Richard B Rothman
Mar 10, 2005·American Journal of Physiology. Endocrinology and Metabolism·Mary Courtney MooreAlan D Cherrington
Jul 31, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Hiam Abdala-ValenciaJoan M Cook-Mills
Nov 6, 2013·European Journal of Pharmacology·Kevin D JohnstonJohn A Rudd
Jun 29, 2013·Child and Adolescent Psychiatric Clinics of North America·Charles W Popper
Jul 27, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·G E JacobsJ M A van Gerven
Feb 9, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·G E JacobsJ M A van Gerven
Jun 16, 2009·Psychoneuroendocrinology·J Frederieke van VeenFrans G Zitman
Dec 17, 2015·Arthritis Research & Therapy·Tao-Hsiang YangChe-Chun Su
Dec 18, 2007·Neuroscience·K SanoM Fujiwara
Aug 26, 2010·Human Psychopharmacology·Mathew H Gendle, Abbe C Golding
Jun 20, 2014·Alimentary Pharmacology & Therapeutics·D KeszthelyiA A M Masclee
Mar 5, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jacob Pr JacobsenMarc G Caron
Jul 19, 2005·Pharmacology & Therapeutics·Erick H TurnerAaron D Blackwell
Jun 3, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D KeszthelyiA A M Masclee
Jun 29, 2010·Journal of Affective Disorders·Nadia IovienoDavid Mischoulon
Oct 9, 2014·Nutrition Reviews·Emma Childs
Oct 25, 2016·Trends in Pharmacological Sciences·Jacob P R JacobsenMarc G Caron
Aug 23, 2008·Journal of Psychopharmacology·G E JacobsJ M A van Gerven
Mar 1, 2008·Journal of Psychopharmacology·L J C A SmariusH J Gijsman
Sep 18, 2018·Experimental Dermatology·Peng-Yang HsuChe-Chun Su
Apr 30, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jacob P R JacobsenMarc G Caron
Feb 22, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rhonda P Patrick, Bruce N Ames
Mar 11, 2020·Reviews in Endocrine & Metabolic Disorders·Giuseppe FanciulliUNKNOWN NIKE
Mar 14, 2020·Pharmacology Research & Perspectives·Zheng GuanWei Zhao
Nov 30, 2019·Frontiers in Pharmacology·Claudia I PerezRanier Gutierrez
Jan 23, 2021·PLoS Biology·Barbora WaclawikováSahar El Aidy
Mar 5, 2021·Behavioural Pharmacology·Ernesto Limón-BernalHéctor I Rocha-González